Navigation Links
NOVA(R) Renal: A Safe Alternative to Contrast Enhanced MRA/MRI
Date:6/3/2008

Breakthrough Technology Avoids Use of Risky Gadolinium Injections

CHICAGO, June 3 /PRNewswire/ -- VasSol's introduction of NOVA(R) Renal, a gadolinium-free procedure, offers a safe alternative to the standard contrast-enhanced Magnetic Resonance Angiography (MRA) and Magnetic Resonance Imaging (MRI) scans for patients suffering from renal disease. Contrast enhanced renal MRA/MRI has traditionally required the injection of a gadolinium based agent which the FDA has linked to the occurrence of a potentially life-threatening disease, Nephrogenic Systemic Fibrosis (NSF). NOVA(R) Renal provides a comprehensive evaluation of the renal arteries without contrast or ionizing radiation.

Who's at Risk?

According to a report by the Centers for Disease Control (CDC), one in six individuals have kidney disease, threatening their renal function and putting them at greater risk when receiving a gadolinium-enhanced MRI scan.

About NOVA(R)

NOVA(R) is the first commercially available technology to measure actual blood flow rates in individual vessels using MRA/MRI scanners. The technology provides 3-D visualization of blood vessels, as well as quantitative blood flow measurements. NOVA(R) adds a new element to the traditional MRA/MRI scan by merging hemodynamic assessment with anatomic images. Non-invasive blood flow measurements with NOVA(R) provide clinicians with more information for the diagnosis and treatment of vascular disease.

About VasSol

VasSol, is founded on 12 years of multidisciplinary research and clinical work conducted at the University of Illinois at Chicago. Bringing together experts in the fields of circulatory fluid dynamics and computer modeling, VasSol developed NOVA(R), a vascular analysis technology, which helps answer the fundamental questions healthcare professionals confront when treating vascular disease: what is the severity, how is the condition best treated and what is the outcome? The VasSol missi
'/>"/>

SOURCE VasSol
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Advanced Instruments Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories
2. Flat carbonated drinks not an effective alternative to oral rehydration solution
3. Saline is Safe Alternative to Harmful Cough and Cold Products
4. Eastern Remedies: Alternative Treatment for the U.S. Healthcare System
5. Natural Alternatives International, Inc. Announces Third Quarter Results
6. Telemedicine a Cost-Effective Alternative to ER Visits
7. An Alternative to Medicinal Marijuana
8. An Alternative to Surgery for Treating Skin Cancer
9. Send Me An Angel(TM) Pairs Senior Citizens With Their Peers in Alternative Care
10. SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery
11. Angioplasty Proves Reasonable Alternative to Bypass Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...e/ -- Sciton introduces ProLipo,PLUS(TM), an FDA-...ser system,for ablating and melting unwanted fat,...tening. ProLipo PLUS combines 1064 nm and 1319 nm...ing results. Frequently used as an adjunct,to tr...a standalone procedure,for patients who are not c...
(Date:12/1/2008)...EER OF SCIENTIFIC DISCOVERY IN MOLECULAR IMAGING ,...he Radiologic Society of North America (RSNA) hono...ng Researcher of The Year" Award, recognition affo...al significant contributions to the field of radio...er is Professor at Harvard Medical School , as we...
(Date:12/1/2008)...f a million dollars to qualified recipients , ...ilepsy Company (TM), will honor 31 recipients of t...eception in Seattle, WA on Sunday, December 7 duri...The scholarship is awarded to inspiring people who...eek personal growth through higher learning. , ...
(Date:12/1/2008)...Newswire/ -- Transcept Pharmaceuticals,Inc., a p...nounced today that,Glenn A. Oclassen, President &...ticipate at the RBC Capital Markets 2008 Healthcar... "Delivering Novel Drug Solutions: The Future of D... take place on Thursday, December,11, 2008 at 1:3...
Breaking Medicine News(10 mins):Health News:Sciton Introduces ProLipo PLUS(TM), the Most Robust Laser-Assisted Lipolysis System Available 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 2Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 3Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 4Health News:Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel 2
...out 10 percent of women in their mid-20s and about...Women with poor memory // skills are also often i...lements may reverse memory loss in these women. Re...en ages 18 and 35. The women were either anemic, i...
...ows calcium from milk, supplements, or other dairy...oting weight loss ,// so if your mother always tol...he may have been wrong. Participants in the stud...ight. Researchers say if the body consumes enough ...
...eatment plan for Leukemia , doctors rely on indica... to be, // including how the cancer cells look und...story. However, for some patients, those indicator...-risk or low-risk group. Doctors may be left guess...
... happens when a clot blocks blood flow to the brai...ction on their own. //Now, a new study shows patie...oke appear to regain more functional independence ...y, researchers evaluated the outcomes of 167 strok...
Other Medicine News:
(Date:11/30/2008)...-USNewswire/ -- Older adults who exercise regularl... number of small blood vessels in the brain, accor...ting of the Radiological Society of North America ...niversity of North Carolina ( UNC) - Chapel Hill ...lts who exercise to brain scans of those who do no...
(Date:11/28/2008)...Call/ -- Eli Lilly and Company,(NYSE: LLY ) has...sNDA) from,the U.S. Food and Drug Administration ...nagement of chronic pain. Lilly plans to resubmit ... data from a recently completed positive study,in... The decision does not affect duloxetine,s FDA-app...
(Date:11/26/2008)...on and intelligent clinical applications take work..., , CHICAGO, Ill., Nov. 26 /PRNewswire-Firs.../healthcare ) highlights the ACUSON S2000(TM) Aut...,s first multi-use, automated volume breast ultras...nnual Meeting of the Radiological Society of North...
(Date:11/25/2008)...Newswire/ -- Kleinert Kutz and University of Loui...d transplant on Messina, New York resident, Jan "E...d Care Center on Monday, November 24. The innovat...shortly after 9 p.m. in a record nine hours. , ...h/20081125/DC48555-a ) , (Photo: http://www.n...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Daytop NJ to Dedicate New Preparatory School This Week 18370 1Daytop NJ to Dedicate New Preparatory School This Week 18370 2United American Healthcare Corporation to Host Fiscal 2008 Third Quarter Results Conference Call May 13th 18368 1United American Healthcare Corporation to Host Fiscal 2008 Third Quarter Results Conference Call May 13th 18368 2Oncolytics Biotech Inc Announces Details of 2008 Annual Shareholder Meeting 5087 1Oncolytics Biotech Inc Announces Details of 2008 Annual Shareholder Meeting 5087 2Biocept Launches Noninvasive Prenatal Rh 28D 29 Diagnostic at Annual ACOG Scientific Meeting 5085 1Biocept Launches Noninvasive Prenatal Rh 28D 29 Diagnostic at Annual ACOG Scientific Meeting 5085 2
.../PRNewswire-FirstCall/ --,Mymetics Corporation ann...t the Company,s HIV vaccine elicited neutralizing,...l. Mucosal IgA,antibodies are considered as a poss...V. The data were presented by Sylvain,Fleury, Ph.D...presentation titled, "Without Mucosal Adjuvant, Vi...
... Improves Cognition in two,distinct models of Alzh...07 - Prana Biotechnology,Limited (NASDAQ: PRAN / A...he research and development of treatments for,neur...ill present,new data on Prana,s lead Alzheimer,s d...on International Conference on Prevention of,Demen...
Other Medicine Technology:Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 2Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 3Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 4Prana Biotechnology Presents New Key Findings on PBT2 2Prana Biotechnology Presents New Key Findings on PBT2 3Prana Biotechnology Presents New Key Findings on PBT2 4Prana Biotechnology Presents New Key Findings on PBT2 5
...d for stone manipulation and removal in the urinar... to retain its shape following extreme torsion. Th...ture by allowing the basket to open at the base of...ign reduces the likelihood of mucosal damage and p...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r
Used for percutaneous placement of a pigtail catheter in the renal pelvis for nephrostomy drainage. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is
The BioPlex 2200 system is a fully automated bead-based multiplexing immunoassay platform that can deliver up to 2200 results per hour. The system will initially include a panel of assays targeting a
Medicine Products: